0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Small Molecule Drug CDMD Services Market Research Report 2025
Published Date: September 2025
|
Report Code: QYRE-Auto-32A16372
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Small Molecule Drug CDMD Services Market Research Report 2024
BUY CHAPTERS

Global Small Molecule Drug CDMD Services Market Research Report 2025

Code: QYRE-Auto-32A16372
Report
September 2025
Pages:98
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Small Molecule Drug CDMD Services Market

The global market for Small Molecule Drug CDMD Services was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Small molecule drugs refer to relatively small organic molecules that usually enter the body through oral administration or other routes and are used to treat diseases. Small molecule drug services provided by Contract Development and Manufacturing Organizations (CDMOs) cover the entire drug development and manufacturing process.
North American market for Small Molecule Drug CDMD Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Small Molecule Drug CDMD Services is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Small Molecule Drug CDMD Services in Business Use is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Small Molecule Drug CDMD Services include Thermo Fisher Scientific, Catalent, Lonza, Asymchem, Delpharm, Aenova Group, Siegfried Holding, Recipharm AB, Fareva, Almac, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Small Molecule Drug CDMD Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Small Molecule Drug CDMD Services.
The Small Molecule Drug CDMD Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Small Molecule Drug CDMD Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Small Molecule Drug CDMD Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Small Molecule Drug CDMD Services Market Report

Report Metric Details
Report Name Small Molecule Drug CDMD Services Market
Segment by Type
  • Active Pharmaceutical Ingredients and Intermediates
  • Finished Type
Segment by Application
  • Business Use
  • Academic Research
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific, Catalent, Lonza, Asymchem, Delpharm, Aenova Group, Siegfried Holding, Recipharm AB, Fareva, Almac, Cambrex, WuXi AppTec, Charles River, CordenPharma, Jubilant Pharmova, Pharmaron Inc., Porton, Jiuzhou Pharmaceutical, Zhejiang Apeloa, HwaGen
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Small Molecule Drug CDMD Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Small Molecule Drug CDMD Services Market report?

Ans: The main players in the Small Molecule Drug CDMD Services Market are Thermo Fisher Scientific, Catalent, Lonza, Asymchem, Delpharm, Aenova Group, Siegfried Holding, Recipharm AB, Fareva, Almac, Cambrex, WuXi AppTec, Charles River, CordenPharma, Jubilant Pharmova, Pharmaron Inc., Porton, Jiuzhou Pharmaceutical, Zhejiang Apeloa, HwaGen

What are the Application segmentation covered in the Small Molecule Drug CDMD Services Market report?

Ans: The Applications covered in the Small Molecule Drug CDMD Services Market report are Business Use, Academic Research

What are the Type segmentation covered in the Small Molecule Drug CDMD Services Market report?

Ans: The Types covered in the Small Molecule Drug CDMD Services Market report are Active Pharmaceutical Ingredients and Intermediates, Finished Type

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Small Molecule Drug CDMD Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Active Pharmaceutical Ingredients and Intermediates
1.2.3 Finished Type
1.3 Market by Application
1.3.1 Global Small Molecule Drug CDMD Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Business Use
1.3.3 Academic Research
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Small Molecule Drug CDMD Services Market Perspective (2020-2031)
2.2 Global Small Molecule Drug CDMD Services Growth Trends by Region
2.2.1 Global Small Molecule Drug CDMD Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Small Molecule Drug CDMD Services Historic Market Size by Region (2020-2025)
2.2.3 Small Molecule Drug CDMD Services Forecasted Market Size by Region (2026-2031)
2.3 Small Molecule Drug CDMD Services Market Dynamics
2.3.1 Small Molecule Drug CDMD Services Industry Trends
2.3.2 Small Molecule Drug CDMD Services Market Drivers
2.3.3 Small Molecule Drug CDMD Services Market Challenges
2.3.4 Small Molecule Drug CDMD Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Small Molecule Drug CDMD Services Players by Revenue
3.1.1 Global Top Small Molecule Drug CDMD Services Players by Revenue (2020-2025)
3.1.2 Global Small Molecule Drug CDMD Services Revenue Market Share by Players (2020-2025)
3.2 Global Small Molecule Drug CDMD Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Small Molecule Drug CDMD Services Revenue
3.4 Global Small Molecule Drug CDMD Services Market Concentration Ratio
3.4.1 Global Small Molecule Drug CDMD Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Small Molecule Drug CDMD Services Revenue in 2024
3.5 Global Key Players of Small Molecule Drug CDMD Services Head office and Area Served
3.6 Global Key Players of Small Molecule Drug CDMD Services, Product and Application
3.7 Global Key Players of Small Molecule Drug CDMD Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Small Molecule Drug CDMD Services Breakdown Data by Type
4.1 Global Small Molecule Drug CDMD Services Historic Market Size by Type (2020-2025)
4.2 Global Small Molecule Drug CDMD Services Forecasted Market Size by Type (2026-2031)
5 Small Molecule Drug CDMD Services Breakdown Data by Application
5.1 Global Small Molecule Drug CDMD Services Historic Market Size by Application (2020-2025)
5.2 Global Small Molecule Drug CDMD Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Small Molecule Drug CDMD Services Market Size (2020-2031)
6.2 North America Small Molecule Drug CDMD Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Small Molecule Drug CDMD Services Market Size by Country (2020-2025)
6.4 North America Small Molecule Drug CDMD Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Small Molecule Drug CDMD Services Market Size (2020-2031)
7.2 Europe Small Molecule Drug CDMD Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Small Molecule Drug CDMD Services Market Size by Country (2020-2025)
7.4 Europe Small Molecule Drug CDMD Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Small Molecule Drug CDMD Services Market Size (2020-2031)
8.2 Asia-Pacific Small Molecule Drug CDMD Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Small Molecule Drug CDMD Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Small Molecule Drug CDMD Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Small Molecule Drug CDMD Services Market Size (2020-2031)
9.2 Latin America Small Molecule Drug CDMD Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Small Molecule Drug CDMD Services Market Size by Country (2020-2025)
9.4 Latin America Small Molecule Drug CDMD Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Small Molecule Drug CDMD Services Market Size (2020-2031)
10.2 Middle East & Africa Small Molecule Drug CDMD Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Small Molecule Drug CDMD Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Small Molecule Drug CDMD Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Company Details
11.1.2 Thermo Fisher Scientific Business Overview
11.1.3 Thermo Fisher Scientific Small Molecule Drug CDMD Services Introduction
11.1.4 Thermo Fisher Scientific Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.1.5 Thermo Fisher Scientific Recent Development
11.2 Catalent
11.2.1 Catalent Company Details
11.2.2 Catalent Business Overview
11.2.3 Catalent Small Molecule Drug CDMD Services Introduction
11.2.4 Catalent Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.2.5 Catalent Recent Development
11.3 Lonza
11.3.1 Lonza Company Details
11.3.2 Lonza Business Overview
11.3.3 Lonza Small Molecule Drug CDMD Services Introduction
11.3.4 Lonza Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.3.5 Lonza Recent Development
11.4 Asymchem
11.4.1 Asymchem Company Details
11.4.2 Asymchem Business Overview
11.4.3 Asymchem Small Molecule Drug CDMD Services Introduction
11.4.4 Asymchem Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.4.5 Asymchem Recent Development
11.5 Delpharm
11.5.1 Delpharm Company Details
11.5.2 Delpharm Business Overview
11.5.3 Delpharm Small Molecule Drug CDMD Services Introduction
11.5.4 Delpharm Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.5.5 Delpharm Recent Development
11.6 Aenova Group
11.6.1 Aenova Group Company Details
11.6.2 Aenova Group Business Overview
11.6.3 Aenova Group Small Molecule Drug CDMD Services Introduction
11.6.4 Aenova Group Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.6.5 Aenova Group Recent Development
11.7 Siegfried Holding
11.7.1 Siegfried Holding Company Details
11.7.2 Siegfried Holding Business Overview
11.7.3 Siegfried Holding Small Molecule Drug CDMD Services Introduction
11.7.4 Siegfried Holding Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.7.5 Siegfried Holding Recent Development
11.8 Recipharm AB
11.8.1 Recipharm AB Company Details
11.8.2 Recipharm AB Business Overview
11.8.3 Recipharm AB Small Molecule Drug CDMD Services Introduction
11.8.4 Recipharm AB Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.8.5 Recipharm AB Recent Development
11.9 Fareva
11.9.1 Fareva Company Details
11.9.2 Fareva Business Overview
11.9.3 Fareva Small Molecule Drug CDMD Services Introduction
11.9.4 Fareva Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.9.5 Fareva Recent Development
11.10 Almac
11.10.1 Almac Company Details
11.10.2 Almac Business Overview
11.10.3 Almac Small Molecule Drug CDMD Services Introduction
11.10.4 Almac Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.10.5 Almac Recent Development
11.11 Cambrex
11.11.1 Cambrex Company Details
11.11.2 Cambrex Business Overview
11.11.3 Cambrex Small Molecule Drug CDMD Services Introduction
11.11.4 Cambrex Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.11.5 Cambrex Recent Development
11.12 WuXi AppTec
11.12.1 WuXi AppTec Company Details
11.12.2 WuXi AppTec Business Overview
11.12.3 WuXi AppTec Small Molecule Drug CDMD Services Introduction
11.12.4 WuXi AppTec Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.12.5 WuXi AppTec Recent Development
11.13 Charles River
11.13.1 Charles River Company Details
11.13.2 Charles River Business Overview
11.13.3 Charles River Small Molecule Drug CDMD Services Introduction
11.13.4 Charles River Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.13.5 Charles River Recent Development
11.14 CordenPharma
11.14.1 CordenPharma Company Details
11.14.2 CordenPharma Business Overview
11.14.3 CordenPharma Small Molecule Drug CDMD Services Introduction
11.14.4 CordenPharma Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.14.5 CordenPharma Recent Development
11.15 Jubilant Pharmova
11.15.1 Jubilant Pharmova Company Details
11.15.2 Jubilant Pharmova Business Overview
11.15.3 Jubilant Pharmova Small Molecule Drug CDMD Services Introduction
11.15.4 Jubilant Pharmova Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.15.5 Jubilant Pharmova Recent Development
11.16 Pharmaron Inc.
11.16.1 Pharmaron Inc. Company Details
11.16.2 Pharmaron Inc. Business Overview
11.16.3 Pharmaron Inc. Small Molecule Drug CDMD Services Introduction
11.16.4 Pharmaron Inc. Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.16.5 Pharmaron Inc. Recent Development
11.17 Porton
11.17.1 Porton Company Details
11.17.2 Porton Business Overview
11.17.3 Porton Small Molecule Drug CDMD Services Introduction
11.17.4 Porton Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.17.5 Porton Recent Development
11.18 Jiuzhou Pharmaceutical
11.18.1 Jiuzhou Pharmaceutical Company Details
11.18.2 Jiuzhou Pharmaceutical Business Overview
11.18.3 Jiuzhou Pharmaceutical Small Molecule Drug CDMD Services Introduction
11.18.4 Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.18.5 Jiuzhou Pharmaceutical Recent Development
11.19 Zhejiang Apeloa
11.19.1 Zhejiang Apeloa Company Details
11.19.2 Zhejiang Apeloa Business Overview
11.19.3 Zhejiang Apeloa Small Molecule Drug CDMD Services Introduction
11.19.4 Zhejiang Apeloa Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.19.5 Zhejiang Apeloa Recent Development
11.20 HwaGen
11.20.1 HwaGen Company Details
11.20.2 HwaGen Business Overview
11.20.3 HwaGen Small Molecule Drug CDMD Services Introduction
11.20.4 HwaGen Revenue in Small Molecule Drug CDMD Services Business (2020-2025)
11.20.5 HwaGen Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Small Molecule Drug CDMD Services Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Active Pharmaceutical Ingredients and Intermediates
 Table 3. Key Players of Finished Type
 Table 4. Global Small Molecule Drug CDMD Services Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 5. Global Small Molecule Drug CDMD Services Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Small Molecule Drug CDMD Services Market Size by Region (2020-2025) & (US$ Million)
 Table 7. Global Small Molecule Drug CDMD Services Market Share by Region (2020-2025)
 Table 8. Global Small Molecule Drug CDMD Services Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 9. Global Small Molecule Drug CDMD Services Market Share by Region (2026-2031)
 Table 10. Small Molecule Drug CDMD Services Market Trends
 Table 11. Small Molecule Drug CDMD Services Market Drivers
 Table 12. Small Molecule Drug CDMD Services Market Challenges
 Table 13. Small Molecule Drug CDMD Services Market Restraints
 Table 14. Global Small Molecule Drug CDMD Services Revenue by Players (2020-2025) & (US$ Million)
 Table 15. Global Small Molecule Drug CDMD Services Market Share by Players (2020-2025)
 Table 16. Global Top Small Molecule Drug CDMD Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMD Services as of 2024)
 Table 17. Ranking of Global Top Small Molecule Drug CDMD Services Companies by Revenue (US$ Million) in 2024
 Table 18. Global 5 Largest Players Market Share by Small Molecule Drug CDMD Services Revenue (CR5 and HHI) & (2020-2025)
 Table 19. Global Key Players of Small Molecule Drug CDMD Services, Headquarters and Area Served
 Table 20. Global Key Players of Small Molecule Drug CDMD Services, Product and Application
 Table 21. Global Key Players of Small Molecule Drug CDMD Services, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global Small Molecule Drug CDMD Services Market Size by Type (2020-2025) & (US$ Million)
 Table 24. Global Small Molecule Drug CDMD Services Revenue Market Share by Type (2020-2025)
 Table 25. Global Small Molecule Drug CDMD Services Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 26. Global Small Molecule Drug CDMD Services Revenue Market Share by Type (2026-2031)
 Table 27. Global Small Molecule Drug CDMD Services Market Size by Application (2020-2025) & (US$ Million)
 Table 28. Global Small Molecule Drug CDMD Services Revenue Market Share by Application (2020-2025)
 Table 29. Global Small Molecule Drug CDMD Services Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 30. Global Small Molecule Drug CDMD Services Revenue Market Share by Application (2026-2031)
 Table 31. North America Small Molecule Drug CDMD Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 32. North America Small Molecule Drug CDMD Services Market Size by Country (2020-2025) & (US$ Million)
 Table 33. North America Small Molecule Drug CDMD Services Market Size by Country (2026-2031) & (US$ Million)
 Table 34. Europe Small Molecule Drug CDMD Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 35. Europe Small Molecule Drug CDMD Services Market Size by Country (2020-2025) & (US$ Million)
 Table 36. Europe Small Molecule Drug CDMD Services Market Size by Country (2026-2031) & (US$ Million)
 Table 37. Asia-Pacific Small Molecule Drug CDMD Services Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 38. Asia-Pacific Small Molecule Drug CDMD Services Market Size by Region (2020-2025) & (US$ Million)
 Table 39. Asia-Pacific Small Molecule Drug CDMD Services Market Size by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Small Molecule Drug CDMD Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 41. Latin America Small Molecule Drug CDMD Services Market Size by Country (2020-2025) & (US$ Million)
 Table 42. Latin America Small Molecule Drug CDMD Services Market Size by Country (2026-2031) & (US$ Million)
 Table 43. Middle East & Africa Small Molecule Drug CDMD Services Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 44. Middle East & Africa Small Molecule Drug CDMD Services Market Size by Country (2020-2025) & (US$ Million)
 Table 45. Middle East & Africa Small Molecule Drug CDMD Services Market Size by Country (2026-2031) & (US$ Million)
 Table 46. Thermo Fisher Scientific Company Details
 Table 47. Thermo Fisher Scientific Business Overview
 Table 48. Thermo Fisher Scientific Small Molecule Drug CDMD Services Product
 Table 49. Thermo Fisher Scientific Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 50. Thermo Fisher Scientific Recent Development
 Table 51. Catalent Company Details
 Table 52. Catalent Business Overview
 Table 53. Catalent Small Molecule Drug CDMD Services Product
 Table 54. Catalent Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 55. Catalent Recent Development
 Table 56. Lonza Company Details
 Table 57. Lonza Business Overview
 Table 58. Lonza Small Molecule Drug CDMD Services Product
 Table 59. Lonza Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 60. Lonza Recent Development
 Table 61. Asymchem Company Details
 Table 62. Asymchem Business Overview
 Table 63. Asymchem Small Molecule Drug CDMD Services Product
 Table 64. Asymchem Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 65. Asymchem Recent Development
 Table 66. Delpharm Company Details
 Table 67. Delpharm Business Overview
 Table 68. Delpharm Small Molecule Drug CDMD Services Product
 Table 69. Delpharm Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 70. Delpharm Recent Development
 Table 71. Aenova Group Company Details
 Table 72. Aenova Group Business Overview
 Table 73. Aenova Group Small Molecule Drug CDMD Services Product
 Table 74. Aenova Group Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 75. Aenova Group Recent Development
 Table 76. Siegfried Holding Company Details
 Table 77. Siegfried Holding Business Overview
 Table 78. Siegfried Holding Small Molecule Drug CDMD Services Product
 Table 79. Siegfried Holding Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 80. Siegfried Holding Recent Development
 Table 81. Recipharm AB Company Details
 Table 82. Recipharm AB Business Overview
 Table 83. Recipharm AB Small Molecule Drug CDMD Services Product
 Table 84. Recipharm AB Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 85. Recipharm AB Recent Development
 Table 86. Fareva Company Details
 Table 87. Fareva Business Overview
 Table 88. Fareva Small Molecule Drug CDMD Services Product
 Table 89. Fareva Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 90. Fareva Recent Development
 Table 91. Almac Company Details
 Table 92. Almac Business Overview
 Table 93. Almac Small Molecule Drug CDMD Services Product
 Table 94. Almac Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 95. Almac Recent Development
 Table 96. Cambrex Company Details
 Table 97. Cambrex Business Overview
 Table 98. Cambrex Small Molecule Drug CDMD Services Product
 Table 99. Cambrex Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 100. Cambrex Recent Development
 Table 101. WuXi AppTec Company Details
 Table 102. WuXi AppTec Business Overview
 Table 103. WuXi AppTec Small Molecule Drug CDMD Services Product
 Table 104. WuXi AppTec Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 105. WuXi AppTec Recent Development
 Table 106. Charles River Company Details
 Table 107. Charles River Business Overview
 Table 108. Charles River Small Molecule Drug CDMD Services Product
 Table 109. Charles River Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 110. Charles River Recent Development
 Table 111. CordenPharma Company Details
 Table 112. CordenPharma Business Overview
 Table 113. CordenPharma Small Molecule Drug CDMD Services Product
 Table 114. CordenPharma Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 115. CordenPharma Recent Development
 Table 116. Jubilant Pharmova Company Details
 Table 117. Jubilant Pharmova Business Overview
 Table 118. Jubilant Pharmova Small Molecule Drug CDMD Services Product
 Table 119. Jubilant Pharmova Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 120. Jubilant Pharmova Recent Development
 Table 121. Pharmaron Inc. Company Details
 Table 122. Pharmaron Inc. Business Overview
 Table 123. Pharmaron Inc. Small Molecule Drug CDMD Services Product
 Table 124. Pharmaron Inc. Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 125. Pharmaron Inc. Recent Development
 Table 126. Porton Company Details
 Table 127. Porton Business Overview
 Table 128. Porton Small Molecule Drug CDMD Services Product
 Table 129. Porton Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 130. Porton Recent Development
 Table 131. Jiuzhou Pharmaceutical Company Details
 Table 132. Jiuzhou Pharmaceutical Business Overview
 Table 133. Jiuzhou Pharmaceutical Small Molecule Drug CDMD Services Product
 Table 134. Jiuzhou Pharmaceutical Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 135. Jiuzhou Pharmaceutical Recent Development
 Table 136. Zhejiang Apeloa Company Details
 Table 137. Zhejiang Apeloa Business Overview
 Table 138. Zhejiang Apeloa Small Molecule Drug CDMD Services Product
 Table 139. Zhejiang Apeloa Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 140. Zhejiang Apeloa Recent Development
 Table 141. HwaGen Company Details
 Table 142. HwaGen Business Overview
 Table 143. HwaGen Small Molecule Drug CDMD Services Product
 Table 144. HwaGen Revenue in Small Molecule Drug CDMD Services Business (2020-2025) & (US$ Million)
 Table 145. HwaGen Recent Development
 Table 146. Research Programs/Design for This Report
 Table 147. Key Data Information from Secondary Sources
 Table 148. Key Data Information from Primary Sources
 Table 149. Authors List of This Report


List of Figures
 Figure 1. Small Molecule Drug CDMD Services Picture
 Figure 2. Global Small Molecule Drug CDMD Services Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Small Molecule Drug CDMD Services Market Share by Type: 2024 VS 2031
 Figure 4. Active Pharmaceutical Ingredients and Intermediates Features
 Figure 5. Finished Type Features
 Figure 6. Global Small Molecule Drug CDMD Services Market Size by Application (2020-2031) & (US$ Million)
 Figure 7. Global Small Molecule Drug CDMD Services Market Share by Application: 2024 VS 2031
 Figure 8. Business Use Case Studies
 Figure 9. Academic Research Case Studies
 Figure 10. Small Molecule Drug CDMD Services Report Years Considered
 Figure 11. Global Small Molecule Drug CDMD Services Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 12. Global Small Molecule Drug CDMD Services Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Small Molecule Drug CDMD Services Market Share by Region: 2024 VS 2031
 Figure 14. Global Small Molecule Drug CDMD Services Market Share by Players in 2024
 Figure 15. Global Top Small Molecule Drug CDMD Services Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Small Molecule Drug CDMD Services as of 2024)
 Figure 16. The Top 10 and 5 Players Market Share by Small Molecule Drug CDMD Services Revenue in 2024
 Figure 17. North America Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 18. North America Small Molecule Drug CDMD Services Market Share by Country (2020-2031)
 Figure 19. United States Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 20. Canada Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. Europe Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. Europe Small Molecule Drug CDMD Services Market Share by Country (2020-2031)
 Figure 23. Germany Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. France Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. U.K. Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Italy Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. Russia Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. Nordic Countries Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Asia-Pacific Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Asia-Pacific Small Molecule Drug CDMD Services Market Share by Region (2020-2031)
 Figure 31. China Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Japan Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. South Korea Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Southeast Asia Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. India Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Australia Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Latin America Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Latin America Small Molecule Drug CDMD Services Market Share by Country (2020-2031)
 Figure 39. Mexico Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Brazil Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Middle East & Africa Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Middle East & Africa Small Molecule Drug CDMD Services Market Share by Country (2020-2031)
 Figure 43. Turkey Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Saudi Arabia Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. UAE Small Molecule Drug CDMD Services Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Thermo Fisher Scientific Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 47. Catalent Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 48. Lonza Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 49. Asymchem Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 50. Delpharm Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 51. Aenova Group Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 52. Siegfried Holding Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 53. Recipharm AB Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 54. Fareva Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 55. Almac Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 56. Cambrex Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 57. WuXi AppTec Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 58. Charles River Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 59. CordenPharma Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 60. Jubilant Pharmova Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 61. Pharmaron Inc. Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 62. Porton Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 63. Jiuzhou Pharmaceutical Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 64. Zhejiang Apeloa Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 65. HwaGen Revenue Growth Rate in Small Molecule Drug CDMD Services Business (2020-2025)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Cephalosporin APIs and Cephalosporin Intermediates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19G16926
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global ELISA Immunoassay Plates Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-7Z17064
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Ready-to-Use ELISA Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-20P20045
Thu Sep 25 00:00:00 UTC 2025

Add to Cart

Global Moxidectin Injection Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-3Z19977
Thu Sep 25 00:00:00 UTC 2025

Add to Cart